Avinger to Announce Third Quarter 2022 Results on November 9

Rhea-AI Summary

Avinger, Inc. (NASDAQ:AVGR) announced that it will release its third quarter 2022 financial results on November 9, 2022, after market close. The company, known for its innovative catheter-based system that addresses vascular disease, will host a conference call at 1:30 PM PT / 4:30 PM ET. Interested parties can join by phone or via a live webcast available on their website. A replay will be accessible shortly after the call concludes.

Positive

• Avinger's proprietary technology targets a significant market, with over 12 million affected by Peripheral Artery Disease (PAD) in the U.S.
• The company is the first to market with an intravascular image-guided, catheter-based system specifically for vascular disease diagnosis and treatment.

Negative

• None.

REDWOOD CITY, CA / ACCESSWIRE / November 1, 2022 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced that it will release its financial results for the third quarter 2022 after the close of trading on Wednesday, November 9, 2022. The Company will host a conference call beginning at 1:30pm PT/4:30pm ET.

To join the call by telephone, please dial +1-973-528-0011 and use passcode 445270. A live webcast of the conference call will be available online from the investor relations page of the Company's corporate website at www.avinger.com.

A replay of the webcast will be made available on Avinger's website, www.avinger.com, shortly after completion of the call.

About Avinger, Inc.

Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to affect over 12 million people in the U.S. and over 200 million worldwide. Avinger is dedicated to radically changing the way vascular disease is treated through its Lumivascular platform, which currently consists of the Lightbox imaging console, the Ocelot and Tigereye^TM family of chronic total occlusion (CTO) catheters, and the Pantheris® family of atherectomy devices. Avinger is based in Redwood City, California. For more information, please visit www.avinger.com.

Follow Avinger on Twitter and Facebook.

Investor Contact:

Matt Kreps
Darrow Associates Investor Relations
(214) 597-8200
mkreps@darrowir.com

SOURCE: Avinger, Inc.

View source version on accesswire.com:
https://www.accesswire.com/723235/Avinger-to-Announce-Third-Quarter-2022-Results-on-November-9

FAQ

When will Avinger announce its third quarter 2022 financial results?

Avinger will announce its third quarter 2022 financial results on November 9, 2022.

What time will the Avinger conference call take place?

The conference call will begin at 1:30 PM PT / 4:30 PM ET.

How can I join Avinger's conference call?

You can join Avinger's conference call by dialing +1-973-528-0011 with passcode 445270 or via their live webcast on the investor relations page of their website.

What products does Avinger offer for vascular disease?

Avinger offers the Lumivascular platform, including the Lightbox imaging console and a range of catheters and atherectomy devices.

What is the market potential for Avinger's technology?

Avinger's technology targets the treatment of Peripheral Artery Disease, which affects over 200 million people worldwide.